Kyle Rose
Stock Analyst at Canaccord Genuity
(2.66)
# 2,218
Out of 5,090 analysts
114
Total ratings
53.26%
Success rate
13.71%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $33.48 | -19.35% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $304.49 | +6.41% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $364.02 | +19.50% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $91.10 | -22.06% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $27.02 | +162.77% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.42 | +52.57% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.46 | +584.93% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $21.45 | +2.56% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $65.49 | +129.04% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.98 | +8,960.40% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $19.68 | +37.20% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.15 | +1,204.35% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $33.32 | -54.98% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $157.82 | -22.70% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $5.57 | -28.19% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.09 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $94.28 | +32.58% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $33.48
Upside: -19.35%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $304.49
Upside: +6.41%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $364.02
Upside: +19.50%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $91.10
Upside: -22.06%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $27.02
Upside: +162.77%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.42
Upside: +52.57%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $21.45
Upside: +2.56%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $65.49
Upside: +129.04%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.98
Upside: +8,960.40%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $19.68
Upside: +37.20%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.15
Upside: +1,204.35%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $33.32
Upside: -54.98%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $157.82
Upside: -22.70%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $5.57
Upside: -28.19%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.09
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $94.28
Upside: +32.58%